P. De Doncker

发表

Pharmacokinetics of orally administered antifungals in onychomycosis

P. De Doncker, Piet De Doncker, 1999, International journal of dermatology.

A double-blind vehicle-controlled study of R 68 151 in psoriasis: a topical 5-lipoxygenase inhibitor.

H. Degreef, K. de Beule, G. Cauwenbergh, 1990, Journal of the American Academy of Dermatology.

Antifungal pulse therapy for onychomycosis. A pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole.

G. Piérard, P. Jacqmin, F. Odds, 1996, Archives of dermatology.

Prolonged effects of antidandruff shampoos ‐ time to recurrence of Malassezia ovalis colonization of skin

J. Arrese, G. Piérard, C. Piérard‐franchimont, 1997, International journal of cosmetic science.

Pharmacokinetic interaction between TMC114/ritonavir and tenofovir disoproxil fumarate in healthy volunteers.

A. Hill, M. Peeters, R. Hoetelmans, 2007, British journal of clinical pharmacology.

Itraconazole pulse therapy for the treatment of Candida onychomycosis

E. Haneke, Ak Gupta, P. De Doncker, 2001, Journal of the European Academy of Dermatology and Venereology : JEADV.

Optical profilometry of nail dystrophies.

N. Nikkels‐Tassoudji, G. Piérard, C. Piérard‐franchimont, 1995, Dermatology.

Current management of onychomycosis. An overview.

A. Gupta, R. Scher, P. De Doncker, 1997, Dermatologic clinics.

Onychomycosis. New therapies for an old disease.

N. Shear, Aditya K. Gupta, A. Gupta, 1996, The Western journal of medicine.

Treatment of tinea capitis with itraconazole capsule pulse therapy.

R. Summerbell, Aditya K. Gupta, A. Gupta, 1998, Journal of the American Academy of Dermatology.

Itraconazole pulse therapy is effective in the treatment of tinea capitis in children: an open multicentre study

R. Summerbell, C. Lynde, Aditya K. Gupta, 1997, The British journal of dermatology.

Paradoxical response to itraconazole treatment in a patient with onychomycosis caused by Microsporum gypseum.

P. Jacqmin, J. Arrese, G. Piérard, 1995, Annales de la Societe belge de medecine tropicale.

Itraconazole therapy is effective for pedal onychomycosis caused by some nondermatophyte molds and in mixed infection with dermatophytes and molds: a multicenter study with 36 patients.

H. Degreef, G. Piérard, T. Rosen, 1997, Journal of the American Academy of Dermatology.

Posttreatment itraconazole levels in the nail. New implications for treatment in onychomycosis.

J. V. van Cutsem, J. Heykants, R. Woestenborghs, 1992, Journal of the American Academy of Dermatology.

The Use of Itraconazole to Treat Cutaneous Fungal Infections in Children

H. Degreef, Y. de Prost, Aditya K. Gupta, 1999, Dermatology.

Onychomycosis in children: prevalence and treatment strategies.

B. Elewski, C. R. Daniel, N. Shear, 1997, Journal of the American Academy of Dermatology.

Antifungal activity of itraconazole and terbinafine in human stratum corneum: a comparative study.

G. Piérard, J. Arrese, P. De Doncker, 1995, Journal of the American Academy of Dermatology.

Present and potential diagnostic techniques in onychomycosis.

J. Arrese, C. Piérard‐franchimont, P. Doncker, 1996, Journal of the American Academy of Dermatology.

Itraconazole: What clinicians should know?

U. Richarz, S. Pande, P. De Doncker, 2017 .

Itraconazole in the treatment of human mycoses: review of three years of clinical experience.

V. Schuermans, K. Stoops, G. Cauwenbergh, 1987, Reviews of infectious diseases.

Itraconazole compared with griseofulvin in the treatment of tinea corporis/cruris and tinea pedis/manus: an interpretation of the clinical results of all completed double-blind studies with respect to the pharmacokinetic profile.

J. Lachapelle, D. Tennstedt, P. Janssen, 1992, Dermatology.

Itraconazole for the treatment of onychomycosis.

C. R. Daniel, A. Gupta, E. Haneke, 1998, International journal of dermatology.

Lateral edge nail involvement indicates poor prognosis for treating onychomycosis with the new systemic antifungals.

R. Baran, P. De Doncker, 1996, Acta dermato-venereologica.

Fungal cultures on cyanoacrylate skin surface strippings as a dose-finding method for topical antifungals. A placebo-controlled study with 0.25% and 0.50% itraconazole cream.

C. Piérard‐franchimont, G. Cauwenbergh, J. Arrese, 1995, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

New approaches to the treatment of onychomycosis.

D. Roseeuw, P. Doncker, P. De Doncker, 1993, Journal of the American Academy of Dermatology.

Pulse therapy with one-week itraconazole monthly for three or four months in the treatment of onychomycosis.

D. Roseeuw, J. V. van Lint, P. De Doncker, 1995, Cutis.

Economic evaluation of antifungal agents in the treatment of toenail onychomycosis in Germany.

E. van Doorslaer, A. Gupta, E. Haneke, 1996, Dermatology.

Management of fungal skin infections with 15 days itraconazole treatment: a worldwide review.

G. Cauwenbergh, P. De Doncker, 1990, British journal of clinical practice. Supplement.

Itraconazole in the Treatment of Onychomycosis: A Double-Blind Comparison with Miconazole

E. Haneke, A. Heremans, P. De Doncker, 1998, Dermatology.

Onychomycosis caused by Microsporum canis: treatment with itraconazole.

J. V. van Cutsem, M. Laporte, J. André, 1995, Journal of the American Academy of Dermatology.

Safety of Itraconazole in Diabetic Patients

P. Doncker, G. Marynissen, A. Gupta, 1999, Dermatology.

Safety of itraconazole pulse therapy for onychomycosis. An update.

C. R. Daniel, N. Shear, T. Rosen, 1999, Postgraduate medicine.

Itraconazole (R 51 211): A clinical review of its antimycotic activity in dermatology, gynecology, and internal medicine

G. Cauwenbergh, P. De Doncker, 1986 .

Effect of Ketoconazole 1% and 2% Shampoos on Severe Dandruff and Seborrhoeic Dermatitis: Clinical, Squamometric and Mycological Assessments

J. Arrese, C. Piérard‐franchimont, P. Doncker, 2001, Dermatology.

Treatment of Dandruff With a 2% Ketoconazole Scalp Gel

H. Degreef, G. Cauwenbergh, P. De Doncker, 1986, International journal of dermatology.

Ketoconazole Shampoo: Effect of Long-Term Use in Androgenic Alopecia

G. Piérard, C. Piérard‐franchimont, G. Cauwenbergh, 1998, Dermatology.

Effect of ketoconazole-medicated shampoos on squamometry and Malassezia ovalis load in pityriasis capitis.

C. Piérard‐franchimont, G. Cauwenbergh, A. Heremans, 1996, Cutis.

Itraconazole and terbinafine in perspective. From petri dish to patient.

A. Gupta, P. De Doncker, 1999, Postgraduate medicine.

Tinea manus treated with 1‐week itraconazole vs. terbinafine

H. Degreef, Aditya K. Gupta, P. De Doncker, 2000, International journal of dermatology.

Itraconazole and terbinafine in perspective: from petri dish to patient.

P. De Doncker, 1999, Journal of the European Academy of Dermatology and Venereology : JEADV.

Yellow nail syndrome and onychomycosis. Experience with itraconazole pulse therapy combined with vitamin E.

C. Luyten, J. André, P. De Doncker, 1996, Dermatology.

Week 48 analysis of once-daily vs. twice-daily darunavir/ritonavir in treatment-experienced HIV-1-infected patients

Beatriz Grinsztejn, K. Ruxrungtham, P. Cahn, 2011, AIDS.

Use of topical ketanserin in the treatment of skin ulcers: a double-blind study.

P. Lewi, P. Janssen, K. de Beule, 1989, Journal of the American Academy of Dermatology.

No evidence of resistance to itraconazole in a prospective real-world trial of dermatomycosis in India

A. Villasis-Keever, D. Fife, K. Shalayda, 2023, PLoS ONE.

Treatment of hyperkeratotic skin diseases with R 68151, a topical 5-lipoxygenase inhibitor: four case reports.

H. Degreef, R. Rooman, M. Morren, 1992, Archives of dermatology.

Treatment of tinea capitis with itraconazole capsule pulse therapy

R. Summerbell, Aditya K. Gupta, P. Doncker, 1998 .